With Mpox Surging in DRC, CCP Rolls out Campaign
A new, more infectious strain of mpox is infecting 1,000 people in DRC a week. CCP is hoping to help slow the spread.
A new, more infectious strain of mpox is infecting 1,000 people in DRC a week. CCP is hoping to help slow the spread.
CCP used technology to quickly assess attitudes and barriers to COVID-19 vaccinations — and to respond with new messages to increase vaccine uptake.
Working with the government, CCP helped some of the most vulnerable people in Bangladesh access COVID-19 vaccines last month. Now, building on that success, another mass vaccination is scheduled for next weekend.
The U.S. Agency for International Development has awarded nearly $6.5 million to the Johns Hopkins Center for Communication Programs to promote the uptake of COVID-19 vaccines across 13 countries in Africa, Asia and Latin America.
We look back at some of the top stories we told about CCP in 2019, and look forward to sharing more of CCP’s great work in the new year.
“Have vaccines become victims of their own success?” asks CCP’s Executive Director Susan Krenn. “Have we forgotten how many people used to become sick and die from these diseases?”
Scientific evidence doesn’t seem to carry the same weight it used to. In the new era of “alternative facts,” it can be especially difficult to effectively communicate with people in order to convince them to behave in their best interests. Take the case of childhood
Receive the latest news and updates, tools, events and job postings in your inbox every month